Matthias Bozza
Director, Research & Development Head of Strategy CPTx
Seminars
Wednesday 16th September 2026
Panel Discussion: Aligning Preclinical Model Selection with Regulatory Expectations to Improve Translation & Approval Confidence
2:30 pm
- Evaluating mouse and non-human primate model translatability to improve clinical predictability
- Comparing model suitability across therapy types to highlight strategic differences that reduce regulatory risk
- Discussing gaps between required regulatory model data and biopharma efficacy needs to align development strategies with translational approval
Tuesday 15th September 2026
Non-Viral ssDNA Vector Delivery Strategies to Optimize Persistence & Patient Safety
1:30 pm
- In vivo immune cell engineering with ssDNA
- Developing strategies to allow long term persistence and gene expression
- Preclinical evidence and scale up
